Hormone therapy for prostate cancer is also known as androgen deprivation therapy (ADT). cannot grow or survive without , which include and other male hormones. Hormone therapy decreases the amount of androgens in a man's body. Reducing androgens can slow the growth of the cancer and even ...
前列腺癌新辅助治疗是指在前列腺癌根治性切除术(RP)或根治性放疗(Radical radiotherapy, RT)之前进行的治疗,针对RP术前新辅助治疗,目前主要包括新辅助内分泌治疗(Neoadjuvant hormone therapy, NHT),新辅助化疗(Neoadjuvant chemotherapy, NCT...
摘要号:LBA70 英文标题:Adding metformin to androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC): Overall survival (OS) results from the multi-arm, multi-stage rando...
Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.(Abstract #LBA2) Background: Docetaxel (D) improves OS of men with mPrCa who have progressed on androgen depr...
1. Silke Gillessen, et al. Adding metformin to androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC): Overall survival (OS) results from the multi-arm, multi-stage randomised platform trial STAMPEDE. ESMO 2024. LBA70 ...
6. Irani J,Salomon L,Oba R et al. Efficacy of venlafaxine,medroxyprogesterone acetate,and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer:a double-blind,randomised trial. Lancet Oncol 2010;11:147-154. ...
"Whenever doctors are recommending hormone therapy for patients, they need to have detailed discussions with them about the pros and cons, because the benefit of ADT is going to be different for every patient," senior author Paul L. Nguyen, MD, from Brigham and Women's Hospital and Harvard ...
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens
Yanagisawa, T., Kimura, T., Hata, K. et al. Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis. World J Urol 41, 2051–2062 (2023)....
Receiving androgen-deprivation therapy (ADT) on an intermittent basis does not appear to be a wise choice for men with metastatic hormone-sensitive prostate cancer, according to alandmark trial publishedin the April 4 issue of theNew England Journal of Medicine. ...